Rafael Andreu
Overview
Explore the profile of Rafael Andreu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Medina-Gil D, Palomo L, Navarro V, Lazaro G, Martin-Mur B, Hernandez C, et al.
Haematologica
. 2025 Mar;
PMID: 40079085
Continuous treatment with ibrutinib not only exerts tumor control but also enhances T cell function in patients with chronic lymphocytic leukemia (CLL). We conducted longitudinal multi-omics analyses in samples from...
2.
Rodenas Quinonero I, Marco-Ayala J, Chen-Liang T, de la Cruz-Vicente F, Baumann T, Navarro J, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766089
Background: Assessment of bone marrow infiltration (BMI) is part of the initial staging of mantle cell lymphoma (MCL), although BMI evaluated by biopsy (BMB) is not considered significant in the...
3.
Abrisqueta P, Gonzalez-Barca E, Ferra C, Rios-Herranz E, Fernandez De La Mata M, Delgado J, et al.
EClinicalMedicine
. 2024 Jun;
73:102642.
PMID: 38841711
Background: BTK inhibitors have been concurrently administered with anti-CD20 monoclonal antibodies (mAbs) in chronic lymphocytic leukemia (CLL). However, the optimal regimen for combining these two drugs remains pending. Methods: This...
4.
de la Asuncion C, Gimenez E, Hernandez-Boluda J, Terol M, Albert E, Lopez J, et al.
J Med Virol
. 2023 Jul;
95(7):e28933.
PMID: 37403897
It is unknown whether Torque Teno virus (TTV) DNA load monitoring could anticipate the development of infectious events in hematological patients undergoing treatment with small molecular targeting agents. We characterized...
5.
de la Asuncion Carlos S, Gimenez E, Hernandez-Boluda J, Terol M, Albert E, Lopez-Jimenez J, et al.
Br J Haematol
. 2023 Jan;
200(6):e58-e61.
PMID: 36652997
No abstract available.
6.
Rodenas-Quinonero I, Chen-Liang T, Martin-Santos T, Salar A, Fernandez-Gonzalez M, Celades C, et al.
Cancer Med
. 2022 Nov;
12(6):6536-6546.
PMID: 36373169
Backgound: In the workup of follicular lymphoma (FL), bone marrow biopsy (BMB) assessment is a key component of FLIPI and FLIPI2, the most widely used outcome scores. During the previous...
7.
Olloqui-Sariego J, Perez-Mejias G, Marquez I, Guerra-Castellano A, Calvente J, De la Rosa M, et al.
Biochim Biophys Acta Bioenerg
. 2022 Jun;
1863(7):148570.
PMID: 35643148
Post-translational modifications and naturally occurring mutations of cytochrome c have been recognized as a regulatory mechanism to control its biology. In this work, we investigate the effect of such in...
8.
Ibanez M, Such E, Liquori A, Avestisyan G, Andreu R, Vicente A, et al.
Diagnostics (Basel)
. 2022 Apr;
12(4).
PMID: 35454001
According to current guidelines, in chronic lymphocytic leukemia (CLL), only the molecular status must be evaluated prior to every treatment's initiation. However, additional heterogeneous genetic events are known to confer...
9.
Marquez I, Perez-Mejias G, Guerra-Castellano A, Olloqui-Sariego J, Andreu R, Calvente J, et al.
FEBS Open Bio
. 2021 Aug;
11(12):3304-3323.
PMID: 34455704
Post-translational modifications frequently modulate protein functions. Lysine acetylation in particular plays a key role in interactions between respiratory cytochrome c and its metabolic partners. To date, in vivo acetylation of...
10.
Romero S, Balaguer-Rosello A, Montoro J, Beneit P, Martinez A, Ruiz C, et al.
Ther Adv Hematol
. 2021 Aug;
12:20406207211038181.
PMID: 34434538
The poor prognosis of refractory or relapsed (R/R) classical Hodgkin's lymphoma (cHL) after autologous stem cell transplantation has improved greatly due to the introduction of brentuximab vedotin and PD-1 inhibitors....